Advancing Photonics for Next-Generation Medical Technologies

Advancing Photonics for Next-Generation Medical Technologies

December 2024

Advancing Photonics for Next-Generation Medical Technologies

Photonics for device development and diagnostics in healthcare.

39 partners from 9 different countries have joined for the PhotonMed project, which is funded with 32 million EUR by the ChipsJU/EU and national funding agencies. The goal is to develop and validate advanced photonics technologies for medical applications. The broad consortium of project partners, who range from research to manufacturing and end-users, are all coordinated by VTT in Finland.

PhotonMed builds on the established MedPhab pilot line model, testing its innovations through 16 pilot cases led by end-user companies. These technologies are designed to accelerate product development, shorten time-to-market, and become accessible to the wider industry through an open-access framework. Pilot case application examples include in vitro diagnostics, such as DNA analytics, in-vivo diagnostics such as the use of catheters for monitoring cardiovascular diseases and personalized monitoring – personalized applications encompass spectral monitoring of physiological conditions in home settings.

ficonTEC is contributing to the PhotonMed project to strengthen its capabilities in the development and manufacturing of photonics-based medical devices. “We are proud to join the PhotonMed consortium, aiming to enhance our integration and production technologies in the biomedical sector while significantly advancing our capabilities to miniaturize and package cutting-edge solutions for the medical device industry. We expect to develop and implement automated production methods that will streamline the complex assembly processes of photonics-related medical devices, setting new standards for efficiency and reliability,” says Dr. Moritz Seyfried, Director of R&D at ficonTEC.

Through its involvement in PhotonMed, ficonTEC aims to enhance its expertise in integration and production technologies essential for meeting ISO 13485 standards, enabling high-volume manufacturing of photonics-based medical devices.

This collaboration creates valuable opportunities for future partnerships, enhancing the company’s capacity to innovate and address the growing demand for advanced devices in healthcare and telecommunications. By leveraging expertise and insights gained from the project, ficonTEC is positioned to strengthen its market presence and drive technological progress for its industrial partners.